Company Update Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Stelis Biopharma's flagship facility receives EIR from the USFDA on the successful closure of its inspection specific to Drug-Device Combination Products